a new view of the spectrum of her2 expression and significance of her2 low in breast cancer
Published 1 year ago • 2.1K plays • Length 1:25:22Download video MP4
Download video MP3
Similar videos
-
1:20:02
her2-low expression in breast cancer: opportunities for expanding treatment benefit to more patients
-
59:44
new perspectives on the full spectrum of her2 expression in breast cancer
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
0:41
investigating the influence of her2 low status in lbc
-
1:30:06
moving toward expanded precision treatment of her2- or her3-driven breast, gi, lung & other cancers
-
6:51
adcs for her2 and her2-low breast cancer
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
1:26
genomic and transcriptomic landscape of her2-low breast cancer
-
0:30
the role of serds in the treatment landscape of patients with er /her2- breast cancer
-
0:34
future role of immunotherapy in her2 breast cancer
-
1:10
the evolution of her2-low-positive breast cancer as a clinical subtype
-
1:27:49
biomarker testing for new therapeutic options targeting her2, her3, and trop2 in solid tumors
-
2:30
prognostic value of her2-low status in breast cancer: a systematic review and meta-analysis
-
1:16
her2-low expression in breast cancer
-
1:45
the comprehensive genomic characterization of her2-low breast cancer
-
8:31
#esmo21 expert video report on her2-positive early breast cancer
-
1:19
remaining challenges regarding her2-low breast cancer
-
1:40
dr. wolff discusses the importance of her2 testing